oxideProperties:
| RelatedCategories | AnalyticalStandards,Analytical/Chromatography,Pharmacopeia&MetrologicalInstitutesStandards,USPStandards,USPStandardsI-K |
Description:
Biochem/physiolActions
Ifosfamideisanitrogenmustardcompoundthatisastructuralisomerofcyclophosphamide.IfosfamideisaprodrugthatmustbetransformedbycytochromeP450totheBIOLOGicallyactivecomponent.Itisusedasanantineoplasticagentincancerchemotherapy,butifosfamideismorelikelytocauserenaltoxicitythancyclophosphamide.
Generaldescription
ThisproductisprovidedasdeliveredandspecifiedbytheissuingPharmacopoeia.Allinformationprovidedinsupportofthisproduct,includingSDSandanyproductinformationleafletshavebeendevelopedandissuedundertheAuthorityoftheissuingPharmacopoeia.ForfurtherinformationandsupportpleasegotothewebsiteoftheissuingPharmacopoeia
.
OtherNotes
Salesrestrictionsmayapply.
USPissuedSDScanbefoundhere
.
Safety:
Symbol


GHS06,GHS08
Hazardstatements
H301-H319-H340-H350-H360
Precautionarystatements
MissingPhrase-N15.00950417-P201-P280-P305+P351+P338-P308+P313